Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials

1 Jan 2005

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune responses and vaccinations
Share to Immunodeficiency and Autoimmune Disorders
Share to Tuberculosis Research and Epidemiology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 15687027
DOI: 10.1016/j.tube.2004.09.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trialsPMID 15687027Read ↗

BCG VaccinesSemantic proximity Read ↗

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-GuérinSemantic proximity Read ↗

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trialsSemantic proximity Read ↗

Tuberculosis vaccines — an updateSemantic proximity Read ↗

Advances in protein subunit vaccines against tuberculosisSemantic proximity Read ↗

Genetic Modification of the BCG Vaccine to Overcome Its Limited Efficacy in Adults: A Specialized ReviewSemantic proximity Read ↗

Improving vaccines against tuberculosisSemantic proximity Read ↗

BCG-Prime and boost with Esx-5 secretion system deletion mutant leads to better protection against clinical strains of Mycobacterium tuberculosisSemantic proximity Read ↗

Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memorySemantic proximity Read ↗

Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure miceSemantic proximity Read ↗

Tuberculosis vaccine development: recent progressSemantic proximity Read ↗

Manipulation of BCG vaccine: a double-edged swordSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.